IL-33/ST2 Pathway and Classical Cytokines in End-Stage Heart Failure Patients Submitted to Left Ventricular Assist Device Support: A Paradoxic Role for Inflammatory Mediators?
Figure 1
Regulation of mediators of inflammation in cardiac tissue from ESHF patient of pre-LVAD group, HT control group, and post-LVAD group. Relative quantification of IL-33 (a), ST2 (b), IL-8 (c), TNF-α (d), and IL-6 (e) is shown.
